Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D gene

By Tachedjian M.   Krywult J.   Moore R.J.   Hodgson A.L.M.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1785-1792

Elsevier

Access to resources Recommend Favorite

Foreign gene expression in Corynebacterium pseudotuberculosis: development of a live vaccine vector

By Moore R.J.   Rothel L.   Krywult J.   Radford A.J.   Lund K.   Hodgson A.L.M.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 487-497

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL ( R) adjuvant

By Skeiky Y.A.W.   Coler R.N.   Brannon M.   Stromberg E.   Greeson K.   Thomas Crane R.   Campos-Neto A.   Reed S.G.  

Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. : 3292-3303

Elsevier

Access to resources Recommend Favorite

Corrigendum to ''Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL ( R) adjuvant'' [Vaccine 20 (2002) 3292-3303]

By Skeiky Y.A.W.   Coler R.N.   Brannon M.   Stromberg E.   Greeson K.   Thomas Crane R.   Webb J.R.   Campos-Neto A.   Reed S.G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3783-3783

Elsevier

Access to resources Recommend Favorite

Math Anxiety and Exposure to Statistics in Messages About Genetically Modified Foods: Effects of Numeracy, Math Self-Efficacy, and Form of Presentation

By Silk Kami J.   Parrott Roxanne L.  

Journal of Health Communication, Vol. 19, Iss. 7, 2014-07 ,pp. : 838-852

Taylor & Francis Ltd

Access to resources Recommend Favorite